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SUMMARY. 
Perfusion experiments on an isolated, canine lateral saphenous vein segment preparation 
have shown that noradrenaline causes potent, flow dependent effects, at a threshold 
concentration comparable to that of plasma noradrenaline, when it stimulates the segment 
by diffusion from its microcirculation  (vasa vasorum). The effects caused are opposite to 
those neuronal noradrenaline causes in vivo and that, in the light of the principle that all 
information is transmitted in patterns that need contrast to be detected ʹ star patterns 
need darkness, sound patterns, quietness ʹ has generated the hypothesis that plasma 
noradrenaline  provides the obligatory contrast tissues need to detect and respond to the 
regulatory information encrypted in the diffusion pattern of neuronal noradrenaline.  Based 
on the implications of that hypothesis, the controlled variable of the peripheral 
noradrenergic system is believed to be the maintenance of a set point balance between the 
contrasting effects of plasma and neuronal noradrenaline on a tissue. The hypothalamic 
sympathetic centres are believed to monitor that balance through the level of afferent 
sympathetic traffic they receive from a tissue and to correct any deviation it detects in the 
balance by adjusting the level of efferent sympathetic input it projects to the tissue.  The 
failure of the centres to maintain the correct balance, for reasons intrinsic or extrinsic to 
themselves, is believed to be responsible for degenerative and genetic disorders. When the 
failure causes the balance  to be polarised in favour of the effect of plasma noradrenaline 
that is believed to cause inflammatory diseases like dilator cardiac failure, renal 
hypertension, varicose veins and aneurysms; when it causes it to be polarised in  favour of 
the effect of neuronal noradrenaline that is believed to cause genetic diseases like 
hypertrophic cardiopathy, pulmonary hypertension and stenoses and when, in pregnancy, a 
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factor causes the polarity to favour plasma noradrenaline in all the maternal tissues except 
the uterus and conceptus, where it favours neuronal noradrenaline, that is believed to 
cause preeclampsia.
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INTRODUCTION 
There is virtually universal agreement that plasma noradrenaline (PNA) at its basal 
concentration of 250-300 pg/ml [1] has no functional effect and, consequently, that any 
effect associated with noradrenaline (NA) is attributable solely tŽƚŚĞĚƌƵŐ͛Ɛ
neurotransmitter function [2].  Consistent with that belief, the threshold concentration at 
which intraluminal NA constricts the canine lateral saphenous vein (CLSV) segment is 0.2 µM 
(34.8 ng/ml) NA [3] and the minimum concentration at which NA causes a detectable effect 
when infused into healthy subjects is 1,800 pg/ml [2].  However, the belief PNA has no 
effect at its basal concentration raises serious questions.  Why, for instance, has the 
evolutionary process conserved neuronal noradrenaline (NNA) overspill and PNA uptake if 
PNA has no function? why does adrenaline(ADR) cause dramatic effects at a concentration 
of around 170 pg/ml and PNA cause none at 250 pg/ml plus? why has PNA been shown to 
be capable of causing supra threshold dilator effects on tonically constricted CLSV segments  
at a concentration that may have been as low as 590 pg/ml?[4]. And, finally, and most 
cogently, why do the valves of veins responsive to NA, and only those valves [5], have a 
structure called an agger that forms the core element of a mechanism that enables reflux 
WEůŽǁĞƌĂǀĞŝŶ͛ƐĞůĞǀĂƚĞĚƚŽŶĞďǇƐƚŝŵƵůĂƚŝŶŐit through diffusion from  its 
microcirculation [6]. Aggers have been known to exist for more than two centuries [7] but 
because it was never possible to get an agreement on their function their existence has now 
been virtually forgotten, as evidenced by the fact that most medical dictionaries contain no 
ƌĞĨĞƌĞŶĐĞƚŽƚŚĞŵĂŶĚĂŶǇĐƵƌƌĞŶƚƚĞǆƚďŽŽŬ/ĂŵĂǁĂƌĞŽĨ͕ŝŶĐůƵĚŝŶŐ'ƌĂǇ͛ƐŶĂƚŽŵǇ, 
makes no mention of them.  In my opinion the existence of valve aggers is as good an 
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indication that PNA has a significant functional role as the existence of the valves 
themselves is an indication that the movement of blood is circular and not tidal.  
 The aim of this three part paper is two-fold,(1) to demonstrate that PNA has a functional 
role as important as that of NNA and (2) to explain how that role operates in various clinical 
disorders. The first part of the paper describes the effects exogenous NA and overspill NA 
have on isolated segments of the canine lateral saphenous vein (CLSV) and that contrast 
with the effects NNA causes in vivo.  However, because those effects cannot be duplicated 
experimentally in vivo, because of a masking effect of efferent sympathetic activity, they 
have beendismissed, up to now, as experimental artifacts. The second part of the paper 
uses the findings described in part one as the basis for two constructs, (1) a hypothesis that 
PNA stimulation provides the contrast or, in a  biological context, the lateral inhibitory effect 
adrenergically innervated tissues need to detect and respond to the regulatory information 
encrypted in the spatio-temporal diffusion pattern of NNA and, (2)  a paradigm of the 
peripheral noradrenergic system( NAS) that states the controlled variable of the system is a 
set point ratio or  balance between the contrasting effects of PNA and NNA on a tissue.  The 
system is believed to be controlled by the hypothalamic sympathetic centres that monitor 
the PNA/NNA balance of a tissue through the level of afferent stimulation it receives from 
the tissue and corrects any deviation it detects in the balance by adjusting, up or down, the 
level of efferent sympathetic activity it projects to the tissue. The third part of the paper 
analyses the aetiology of several pathological conditions in the light of the new hypothesis 
and related NAS paradigm. That analysis has concluded that any factor that disturbs the 
balance between the effects of PNA and NNA on a tissue causes remodeling changes in the 
tissue. When a factor shifts the balance in favour of the pro inflammatory effect of PNA, 
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that is believed to cause conditions like dilator cardiac failure, varicose veins, hypertension 
and aneurysms; when it shifts it in favour of the growth promoting, anti-inflammatory effect 
of NNA that is believed to cause conditions like hypertrophic cardiopathy and stenoses, and 
when, in pregnancy, it shifts it in favour of PNA in the mother overall, but not in her uterus 
or conceptus, where it shifts it in favour of NNA, then that is believed to cause 
preeclampsia. 
 The bulk of the experiments on whose findings the new hypothesis and paradigm are 
based, were conducted prior to the discovery of nitric oxide (NO) or to its role being fully 
appreciated. In the circumstance, no formal attempt was made at the time to determine if 
NO might have been responsible for the flow dependent vasodilator effects associated with 
PNA stimulation.  However, the evidence (v.i.) is strongly against that having been the case. 
In addition, little effort was made to classify the various effects of NA on the CLSV segment 
pharmacologically because of the early evidence that the drug sometimes caused 
qualitatively different effects in different parts of the segment at the same time. In the 
circumstance the use of blocker drugs was considered to be potentially confusing and not 
worthwhile, particularly as I employed a technique (v.i.) that made it possible to visibly 
observe the precise nature, extent and location of the effects NA caused.    
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PART 1 
The  first evidence I had that exogenous and overspill endogenous NA could cause dilator 
effects  emerged during a routine pharmacological investigation  of the responses of a 
perfused, doubly cannulated, in vitro preparation of segments of the CLSV to NA (Levophed) 
and electrical stimulation [8],[9]. Early in the course of the investigation an occasional 
segment displayed  bimodal responses to stimulation [10] and that, in the context of the 
constant flow perfusion technique being employed, implied exogenous NA and overspill NA 
were causing dilator as well as constrictor effects.  Initially, the bimodal responses were 
dismissed as experimental artifacts. However, because of a prior clinical interest I had in 
varicose veins I was reluctant to accept that verdict off hand: might it be possible a dilator 
effect of PNA was responsible for the varicosities of varicose veins?  I accepted that 
suggestion would have to be treated with caution because if NA was causing a dilator effect 
then, it seemed, it had to be doing so by stimulating the segment by diffusion from its 
microcirculation. However, as far as was known at the time, no one had ever been able to 
perfuse the microcirculation of a healthy vein by reflux and consistent with that fact, a 
widely cited article [11] claimed that the microcirculation of a vein drains into the lumens of 
neighbouring veins and not into the lumen of its host, implying no channel existed for 
anything perfusing the lumen of a healthy vein segment to perfuse ƚŚĞƐĞŐŵĞŶƚ͛Ɛ
microcirculation.   
However, shortly after becoming aware of the bimodal responses I made a series of 
speculative 3ml injections of isoprenaline (ISO), a proven intraluminal dilator of the CLSV 
segment [9], into the distal end of a major tributary of the segment and found they caused 
dose related, localised constrictor effects [12].  The fact the responses were located 
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upstream from where the injected tributary emptied into the perfused segment (fig 1) and 
upstream also of a competent valve in the lumen of the segment, meant it was impossible 
for ISO to have constricted the segment by an intraluminal effect at the constricted site. By 
exclusion, the only alternative seemed it must have done so by a reflux microcirculatory 
effect. 
                       
 Fig 1.        
Localised constriction (*) of a perfused CLSV segment caused by isoprenaline injected into 
the Lateral Plantar tributary (LPT). 
That that was indeed the case seemed to be confirmed when a solution of ISO and ink were 
injected into the tributary and the ink stained the microcirculation of the perfused segment 
only where ISO constricted it [13]. That established that, contrary to prevailing belief, a 
channel existed between the lumen of the tributary and microcirculation of the CLSV 
segment and that exogenous and overspill NA had probably used it to cause the dilator 
effect of their associated bimodal responses. And since ISO had caused its constrictor effect 
at a threshold concentration of ~ 1ng/ml,[12][13], which is 30-40 times lower than the ~ 
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0.2µM (34.8 ng/ml) threshold at which NA caused its intraluminal constrictor effect [14], it 
was conceivable that PNA, at its basal concentration of around 250-300 pg/ml, could  dilate 
the segment by stimulating it by diffusion from its own microcirculation.  That possibility 
was strengthened by the evidence that the concentration of overspill NA associated with 
standard levels of electrical stimulation of the canine lateral saphenous vein in vivo was 
comparable to the basal concentration of PNA in the human saphenous vein [15]. If 
microcirculatory PNA stimulation was responsible for causing the varicosities of varicose 
vein then that implied it must have a pro inflammatory  effect [16].  
Material and methods. 
Isolated CLSV segments were obtained from large dogs, preferably greyhounds, put down 
by electrocution [9].  Initially, only in vitro segments were employed but after 2-3 years in 
situ segments were far more commonly employed. In situ preparations of combined 
segments of the canine cranial tibial artery and vein were obtained in the same way as the 
in situ CLSV segments.  
 After being doubly cannulated, segments were perfused with oxygenated Tyrode solution 
at 34මC, at constant flow rates of between 35 and 40 ml/min, with drugs being added to the 
perfusion reservoir or injected into the perfusion circuit through a side tap located close to 
the upstream cannula. The responses of segments were monitored in two ways: by 
recording the pressure changes in the perfusion circuit, when a rise in pressure indicated a 
segment was constricting overall and a fall indicated it was dilating overall, and by fixing 
segments with a rapidly acting primary fixative injected into the perfusion circuit as their 
responses reached their peak and subsequently observing the structural changes associated 
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with the responses. The fixative consisted of a pH 6.6-6.8 solution of 2% glutaraldehyde and 
2.5% paraformaldehyde in phosphate buffer.  
When needed, the distributive effect of turbulence was used to increase flow, and the effect 
of drugs, in randomly located or preselected microcirculatory modules. Several means were 
used to induce the turbulence but the most effective and frequently used was floating of a 
length of knotted domestic sewing thread in the perfusate of a segment [17].  When drugs 
were injected intralumenally, rather than added to the perfusate, turbulence was then 
induced by making the injections in an abrupt, pulsatile manner. 
Over one hundred valves in the lumen and tributaries of CLSV segments were examined 
histologically to elucidate the structure of the valve agger and the arrangement of the 
smooth muscle bundles associated with it.  All tissues investigated were fixed by the rapidly 
acting fixative referred to and were serially sectioned, effectively, in random planes at a 
thickness of 7µm, usually. The bases of several cardinal (terminal) valves in the major 
tributaries were also examined by scanning electron microscopy after their cusps had been 
resected.   
Results 
The most significant of the early experimental finding was the evidence that the 
microcirculation of a CLSV segment could be perfused by reflux at a pressure as low as 
33mm Hg when the segment was stimulated by NA and its flow turbulent [18].  That meant 
it was, in theory at least, possible that blood could perfuse ĂǀĞŝŶ͛Ɛmicrocirculation by 
reflux from its lumen at physiological pressures.  Another significant early finding was the 
evidence that an estimated minimum 80% of the blood draining from the microcirculation 
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of the CLSV segment first drained into the bases of the cardinal (terminal) valves of the 
ƐĞŐŵĞŶƚ͛Ɛ tributaries ďĞĨŽƌĞĚƌĂŝŶŝŶŐŝŶƚŽƚŚĞƐĞŐŵĞŶƚ͛Ɛlumen. That information made it 
possible to block a minimum 80% of any  reflux from the lumen of the CLSV segment 
ƉĞƌĨƵƐŝŶŐƚŚĞƐĞŐŵĞŶƚ͛Ɛmicrocirculation by simply putting ties on all the tributaries of a 
segment flush with their junctions with the segment. When that was done it had two 
immediate and highly significant effects: it abolished the occasional bimodal responses and 
ŝƚƐƚƌĞŶŐƚŚĞŶĞĚƚŚĞƐĞŐŵĞŶƚƐ͛ĐŽŶƐƚƌŝĐƚŽƌƌĞƐƉŽŶƐĞƐƚŽexogenous NA and, more 
significantly, electrical stimulation by around 50%.  
Another significant early finding was the evidence that the microcirculation of the CLSV 
segment was composed of modules, each servicing the needs of a 3-5 diameter long section 
of the segment. That made each section a functionally independent unit in the sense its 
response to microcirculatory stimulation is independent of, and potentially different from 
that of every other section [10]. 
The final significant finding provided the first clear statistical evidence of the dilator potency 
of reflux microcirculatory NA stimulation. That was provided by a series of comparisons 
between the responses of two cohorts of in vitro CLSV segments, one 57 in number, the 
other 27, to intraluminal NA and electrical stimulation [12].  The 57 segment cohort had no 
flush ties on their tributaries so their microcirculations received normal levels of reflux while 
the tributaries of the 27 segment cohort had flush ties and their microcirculations received a 
maximum 20% of normal reflux.  Because of receiving so little reflux, with its dilator effect, 
the constrictor responses of the 27 segment cohort to NA and electrical stimulation were 
significantly greater than the responses of the 57 segment cohort. As evidence of that, a 
range of constrictor responses the 57 segment cohort with no ties achieved with 
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concentrations of exogenous NA ranging 0.1 to 0.3 µg/ml was achieved by the 27 segment 
cohort, with ties, with concentrations ranging 0.05-0.1 µg /ml, and a benchmark electrical 
response the 57 segment cohort needed about 500 impulses to achieve was achieved by the 
27 segment cohort with between 250 -300 impulses. In addition, when all 1081 responses of 
the two cohorts of segments to electrical stimulation were analysed it was found only 13 of 
the 57 segment cohort (23%) had achieved a minimum of one 80 mmHg rise in perfusion 
pressure, while 18 of the 27 segment cohort (66%) had achieved that mark.  
Because the differences between the two ĐŽŚŽƌƚƐ͛ƌĞƐƉŽŶƐĞƐŵŝŐŚƚďĞƌĞůĂƚĞĚŝŶƐŽŵĞǁĂǇ
to the use of in vitro segments an experiment was conducted where eleven matched pairs 
of in situ segments were used to construct eleven dose response curves to NA, using five 
concentrations ranging from a threshold of 0.2 µM to 6.0 µM, and where the tributaries of 
one of each pair had flush ties blocking reflux [14]. While there was no significant difference 
between the paired segments at 0.2 µM, there were significant differences at every other 
concentration, with the segments with flush ties and blocked reflux, displaying mean 
constrictor responses 49 to 54% higher than the responses of the segments without ties. In 
brief, regardless of whether in vitro or in situ CLSV segments were involved, an estimated 
minimum 80% reduction in reflux microcirculatory NA perfusion was associated with 
increased constrictor responses of around 50%. 
Aggers and reflux. 
The evidence that the junctional regions of tributaries were involved in some way with a 
ƐĞŐŵĞŶƚ͛Ɛconstrictor response to ISO and reflux  naturally  led to their investigation. An 
initial inspection revealed that virtually every tributary, down to a diameter of around 150-
200 microns, possessed a cardinal (terminal) valve located 2-3 tributary diameters from the 
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tributary junction. However, consistent with belief then, and currently, that valves are cul-
de-sacs, inspection revealed no evidence of any venule opening into the base of the valve 
or, for that matter, into the junctional region. However, on one occasion,when preparing a 
segment for cannulation, I accidentally made an incision into the sinus of a cardinal valve 
and saw blood flowing freely, against gravity, from the base of the valve into the lumen of 
the CLSV for up to twenty minutes. Having seen that, I then used electron microscopy to 
detect the opening from which the bleeding had taken place [4]. Initially, microscopy was 
carried out on the valves of segments that were unstimulated by NA at the time of fixation 
and it found no evidence of any vessel opening into the base of a valve. Instead, all it found 
was a series of deep folds at the bases of the valves (fig 2A). However, later, when segments 
that had been stimulated by NA at the time of fixation were examined, microscopy revealed 
an entirely different picture: all the folds were gone, the bases of the valve were smooth 
and at the base of each valve was a prominent opening, about 100 microns in diameter (fig 
2B).  It was apparent on review that the opening detected in the second set of micrographs 
had been present in the first also but was ĐŽŵƉƌĞƐƐĞĚĂŶĚŚŝĚĚĞŶŝŶƚŚĞǀĂůǀĞ͛ƐĚĞĞƉĨŽůĚƐ
(2A).  
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  Fig  2.   SEM micrographs of the bases of cardinal valves showing (a) the opening of a 
venule (*-*) compressed by the recoil of an agger and (b) the decompressed opening of a 
venule when a CLSV segment was stimulated by  10µM NA and the valve agger was 
consequently stretched.  
  &ƵƌƚŚĞƌŝŶǀĞƐƚŝŐĂƚŝŽŶƌĞǀĞĂůĞĚƚŚĞĨŽůĚƐǁĞƌĞĐĂƵƐĞĚďǇƚŚĞƌĞĐŽŝůŽĨƚŚĞǀĂůǀĞ͛ƐĂŐŐĞƌ͕Ă
dense fibroelastic linear structure, located along the line of attachment of the valve cusp 
and currently believed to be a mere hinge attaching the valve  cusp to the vein wall. In fact 
the agger is a functional valve, whose compression effect  paradoxically assists 
microcirculatory drainage [19], that prevents a venous microcirculatory module being 
perfused by reflux ǁŚĞŶĂǀĞŝŶ͛ƐƚŽŶĞŝƐŶŽƌŵĂů. The effectiveness of the agger in doing that 
was demonstrated by an experiment where Methylene Blue was injected into the sinuses of 
cardinal valves at pressures peaking around 200 mmHg and a minimum 92.56 (±3.16) % of 
the dye was later recovered from the run off of the perfusate within 10 seconds of the 
injection having been completed [20].  
Further investigation revealed the two pairs of smooth muscle bundles project from the 
walls of a vein and/or its tributaries onto each agger. Because the muscles project onto the 
agger from opposite directions, they stretch it when they contract as the tone of a vein 
rises.  That decompresses the venules that normally drain microcirculatory modules into 
valve sinuses and make it possible for the modules to be perfused by reflux when the tone 
of the vein rises and for the PNA in that reflux to then lower the elevated tone to normal 
[6][13].  To enable reflux take place, as the tone of a vein rises the A/V shunts of the 
microcirculatory modules  open [17] and divert the arterial inflow. Effectively, the agger is 
part of a PNA-dependent negative feedback designed to stabilise venous tone.   
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Further evidence of the dilator potency of  microcirculatory PNA stimulation was provided 
by an experiment where, some 20 minutes post-mortem, Tyrode solution was injected into 
tonically constricted CLSV segments filled with blood and caused prominent varicosities on 
the segments (fig 3) [4].  When the experiment was duplicated in segments cleared of blood 
no varicosities resulted. The concentration of PNA in the blood filling the injected segments 
varied from 0.59-1.32ng/ml [4]. 
 
 
Fig. 3.  Varicosities created, some 20 minutes post-mortem, in a tonically constricted CLSV 
ƐĞŐŵĞŶƚďǇƌĞĨůƵǆƉĞƌĨƵƐŝŽŶŽĨƚŚĞƐĞŐŵĞŶƚ͛ƐŵŝĐƌŽĐŝƌĐƵůĂƚŝon with the blood filling the 
lumen of the segment. 
Valve Cannulation.  
Having knowledge of how the valve agger operated made it possible to investigate how a  3-
5 diameter long  section of the CLSV segment, serviced by a single microcirculatory module, 
responded to drugs stimulating it by diffusion from the module.  That investigation was 
made by injecting drugs into a cannulated sinus of a cardinal valve and noting the response 
of the section of the segment whose microcirculatory module had been perfused by the 
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injection. The experiment confirmed the high sensitivity of the section to drugs stimulating 
it through its microcirculation. A typical experiment involved injecting a 1.0 ml bolus of 1µM 
ISO into a valve sinus on three occasions and finding it caused a 174 mmHg rise in the 
overall perfusion pressure of the segment on each occasion [20], compared to the 130 mm 
Hg rise 6.0 µM intraluminal NA would be expected- by extrapolation from a dose response 
curve [14] - to cause. Given that aggers block ~ 93% of any drug injected into a valve sinus 
from perfusing its associated microcirculatory module, the difference in sensitivity to NA 
stimulating a blood vessel through its lumen and through its microcirculation is, in fact, 
much greater than the figures quoted indicate.  One important implication of that fact is 
that PNA is a physiological vasodilator and a pharmacological vasoconstrictor . 
Another cannulation experiment  that  again confirmed the dilator potency of 
microcirculatory PNA involved eliminating the presence of tonically released  NA in the 
microcirculation of a CLSV segment by stimulating the segment with reserpine or 
guanethidine until it ceased to respond to electrical stimulation and then finding that the 
ƐĞŐŵĞŶƚ͛ƐĐŽŶƐƚƌŝĐƚŽƌƌĞƐƉŽŶƐĞƚŽĂϭŵůďŽůƵƐŽĨϭŵD/SO stimulation increased 
significantly, on one occasion by  91%, from an initial 46 to a subsequent 86 mmHg rise in 
perfusion pressure[20].  
The dilator effects of NO and PNA. 
One reason the dilator effect of microcirculatory PNA has not been recognised generally up 
to now is the high profile currently enjoyed by NO and its involvement in a range of effects, 
some of them, like PNA, flow dependent and dilator. Because of that profile any inexplicable 
dilator effect tends to be attributed by default to the action of NO [21] and to the reduced 
bioavailability of endothelial NO associated with inflammatory disorders. The latter is 
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currently attributed to a primary dysfunction of the endothelium but is more likely, I 
believe, to be caused by an inhibitory effect of increased stimulation of the endothelium by 
PNA in inflammatory conditions . Consistent with that belief the reduced bioavailability of 
NO in dilator cardiac failure is responsive to the use of the beta1 blocker nebivolol [22]. 
The coupled segment preparation. 
tŚĞŶĂĚŽŐ͛ƐŚŝŶĚůĞŐŝƐĂŵƉƵƚĂƚĞĚĂƚƚŚĞŬŶĞĞũŽŝŶƚƚŚĞůƵŵĞŶŽĨƚŚĞĐƌĂŶŝĂůƚŝďŝĂůĂƌƚĞƌǇŝƐ
exposed, which makes it possible, by injecting the exposed lumen, to perfuse the 
microcirculations of both the artery and its companion tibial vein by orthograde flow. When 
done, it became possible to compare the responses of the cranial tibial artery and vein to 
orthograde microcirculatory NA stimulation with the responses of the isolated CLSV 
segment to reflux microcirculatory NA stimulation.  That comparison revealed no significant 
difference between the two in respect of dilating in response to microcirculatory NA 
stimulation. It also revealed that both arteries and veins in general have the same type of 
modular construction as the CLSV segment has [23]. Those findings were confirmed when a 
bolus of 3µM NA was injected in a pulsatile manner into the lumen of a tibial artery and  
caused a berry aneurysm on the otherwise constricted artery and  randomly located 
varicosities on the tibial vein (fig 4) [23]. The fact that the vein was not being perfused at the 
time the varicosity was created is presumptive evidence that a dilator effect of NO released 
from the venous endothelium had not been responsible for it.   
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Fig 4.  Photographs of (A) varicosities created in a canine cranial tibial vein and (B) a berry 
aneurysm created in an otherwise constricted canine cranial tibial artery by a pulsatile 
injection of 3µM NA into the lumen of the artery.  
The pro inflammatory effect of microcirculatory PNA.  
The belief that increased  PNA stimulation has a  pro inflammatory effect is based on the 
evidence that repeated episodes of exogenous NA stimulation of perfused CLSV segments 
ŽǀĞƌƚŚĞĐŽƵƌƐĞŽĨĂĚĂǇ͛ƐĞǆƉĞƌŝŵĞŶƚĂƚŝŽŶ caused effects that either mimicked or were 
predictive of those that occur in varicose veins, a classical inflammatory  condition. Among 
the effects that mimicked those  found in varicose veins, and are defining features of that 
condition,  were varicosities, the opening of A/V shunts [17], the formation of blocking 
intimal cushions in arterioles in the wall of varicosities and the loss of the arterioles distal to 
the cushions [24][25]. The predictable consequence of that blockage and loss of arterioles 
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would be tissue hypoxia, another  recognised feature of varicose veins [26].  And that 
hypoxia, in turn, is predictive of yet another recognised feature of varicose veins, viz., a 
replacement of aerobic [27] by anaerobic respiration [28]. 
However, the clearest evidence of the pro inflammatory effect of increased microcirculatory 
PNA simulation was the finding of a fenestrated endothelial cell lining a post capillary venule 
ŽĨƚŚĞ>^sƐĞŐŵĞŶƚ͛ƐŵŝĐƌŽĐŝƌĐƵůĂƚŝŽŶ΀Ϯϰ΁͘ Even though the fenestration was in the 
process of closing down at the time of fixation, it was still big enough, had it existed 
 
Fig. 5. SEM micrograph of a fenestrated endothelial cell lining a post capillary venule in 
the microcirculation of a CLSV segment. 
in vivo, to allow blood extravascate into the interstitial tissue and cause the haemosiderotic 
dermatitis common in patients with chronic varicose veins. In the present context, however, 
the particular significance of  the fenestration lies in the fact that it is known to be caused by 
an increased expression of the pro inflammatory marker TNF-ɲ΀Ϯϵ΁͕ĂůŝŐĂŶĚǁŝƚŚƚŚĞĂďŝůŝƚǇ
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
21 
 
to cause  pro apoptotic inflammatory ĐĂƐĐĂĚĞƐƚŚƌŽƵŐŚĂĐƚŝǀĂƚŝŶŐƐŽĐĂůůĞĚ͞ĚĞĂƚŚ
receptors͟ [30].  
The neurotoxic effect of increased microcirculatory PNA stimulation. 
Assuming increased microcirculatory PNA stimulation is responsible for varicose veins, then 
its most strategic malign effect is the progressive damage it causes to the adrenergic 
plexuses of varicosities [31]. That, at some point, would have the effect of making it 
impossible to maintain the noradrenergic set point ratio of a varicosity because of the 
inability of its damaged adrenergic nerves to release sufficient NNA to maintain the ratio.   
Summary of main findings. 
1. Basal concentrations of PNA have pro-inflammatory effects when it stimulates 
tissues through their microcirculations. 
2. In health, efferent sympathetic activity masks these effects. 
3. The effect of PNA is overwhelmingly flow, not concentration, determined. 
4. PNA stimulation has a neurodegenerative effect.  
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PART 2. 
 
This part of the article explores the implications of the findings in part one . 
The sources and sinks of PNA. 
PNA overspills into the circulation from two sources.  One, the dedicated nerve plexuses 
microcirculations have [32] and the other, the nerve plexuses of the tissues hosting 
microcirculations.  The NNA of the plexuses constricts blood vessels while PNA dilates.  It 
dilates arteries and veins by stimulating them by diffusion from their microcirculations and it 
dilates microcirculations by a flow dependent intraluminal effect [24] [33]. PNA is cleared 
from the blood by uptake into the nerves and mast cells, by monoamine oxidase 
inactivation and pulmonary clearance, the evidence of the latter being the lower 
concentration of PNA in arterial as compared to venous blood [34] and the acute increase in 
pro-inflammatory markers associated with pulmonary bypass procedures [35]. 
Vascular Tone. 
Since PNA is believed to have no effect, vascular tone is attributed at present solely to the 
effect of NNA.  Based on the findings in part one, vascular tone is in fact a resultant  of PNA 
and NNA stimulation of a blood vessel. That is significant because it means when the effect 
of one stimulus is reduced the effect of the other is necessarily increased without there 
having been any increase in its concentration. Evidence to that effect is seen when vein 
grafts are harvested by the traditional method which involves resection of their adventitia 
with the accompanying loss of their microcirculations and PNA stimulation. As soon as that 
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resection occurs, ~95% of grafts go into spasm, due to the effective increase in the 
unopposed constrictor effect of NNA on the grafts. In contrast grafts harvested by a recently 
ŝŶƚƌŽĚƵĐĞĚ͚ŶŽƚŽƵĐŚ͛ƚĞĐŚŶŝƋƵĞƚŚĂƚpreserves their microcirculations rarely go into spasm 
[36], [37].   
In addition to the increased tone, traditionally harvested grafts also display increased 
rigidity.  The evidence of that is seen by the fact that surgeons sometimes have to perfuse 
grafts at pressures as high as 300 mm Hg, in addition to stimulating them with a cocktail of 
vasodilator drugs, to dilate and make them fit for purpose. The rigidity effect is not related 
to the ex vivo nature of grafts because the same effect occurs in the canine ascending aorta 
when its microcirculation is resected in vivo [38΁͕ĂŶĚŝŶĂƌƚĞƌŝĞƐĂĨĨĞĐƚĞĚďǇdĂŬĂǇĂƐƵ͛Ɛ
Disease [39] ĂŶĚtŝůůŝĂŵ͛Ɛ^ǇŶĚƌŽŵĞ΀40] when their microcirculatory modules are blocked 
by inflammatory debris and the sections of the arteries serviced by those modules become 
stenosed and rigid. Rigidity is fact a function of the balance between the number of 
latchbridges created in non-skeletal muscle by the effect of NNA stimulation and the 
number of latchbridges released by the ɴ1 phosphorylating effect of PNA [41] responsible 
for relaxing non-skeletal muscle [42], [43].[44],[45].  
The response to disturbance of the noradrenergic ratio. 
When any factor disturbs the set point noradrenergic ratio of a tissue, the hypothalamic 
sympathetic centres are believed to be alerted to it by a change in the level of afferent 
sympathetic activity they receive from the affected tissue. The centres are then believed to 
become involved in restoring the ratio ʹ in the process masking, but not eliminating, the 
changed effect of PNA - by adjusting the level of efferent sympathetic traffic it projects to 
the tissue. That masking effect is believed to be the reason why no response was detected 
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when NA was infused into healthy subjects until its concentration reached 1,800 pg/ml 
minimum [2].  As the concentration of infused NA increased the level of afferent 
sympathetic activity in the body is believed to have increased. In response to that the 
hypothalamic centres are believed to have increased the level of efferent sympathetic 
activity to the level where the infused NA had no detectable effect. However, because 
hypothalamic neurons have a limited ability to increase their level of activity [46], as the 
concentration of infused NA kept on rising and the level of afferent sympathetic activity it 
caused increased, the hypothalamic neurons eventually reached the limit of their ability to 
increase the level of efferent activity to the point required to maintain the set point 
noradrenergic ratio of tissues. At that point that ratio would be expected to shift in favour of 
PNA stimulation and cause a detectable effect. Based on the experimental findings, the 
point at that shift occurred was when the concentration of infused NA reached 1,800 pg/ml 
minimum [2].   
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 
The credibility of this NAS paradigm rests on its ability to provide an internally coherent 
explanation of a number of findings that relate to the operation of the system and are 
difficult or impossible to account for at present. One is why infused ADR, unlike PNA, causes 
detectable effects at a low picogram concentration, the reason being ADR, unlike NA, 
ĚŽĞƐŶ͛ƚĞǀŽŬĞĂŶŽƉƉŽsing masking effect mediated by itself.  Another is why an association 
exists between increased cardiac microcirculatory flow, increased cardiac afferent 
sympathetic activity and increased efferent sympathetic activity in dilator cardiac failure 
(v.i.) and, conversely, why there is an association between reduced cardiac microcirculatory 
flow and decreased cardiac efferent sympathetic activity in hypertrophic cardiomyopathy 
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[47]. In the latter case the reason is believed to be that reduced cardiac PNA stimulation 
shifts the noradrenergic ratio of the heart in favour of the growth promoting, anti-
inflammatory effect of NNA stimulation on the heart, hence the cardiac hypertrophy effect. 
That same shift in favour of NNA stimulation and hypertrophy occurs in preeclampsia [48] 
where a factor that decreases perfusion of the uterus shifts the noradrenergic ratio of that 
organ in favour of the growth promoting effect of NNA and causes it to hypertrophy [49].   
Finally, the paradigm accounts for the fact that, in life, the level of efferent sympathetic  
activity in the body increases in line with the genetically programmed rise in the 
concentration of PNA [50]. The increased neurotoxic effect of this programmed rise in PNA 
concentration makes it impossible for the NAS to continue stabilising the PNA/NNA ratio at 
the level characteristic of youth and that, I speculate, is responsible for driving the ageing 
process. 
The effect of cholesterol plaques on the noradrenergic ratio. 
Cholesterol plaques are the commonest cause of increasing the flow dependent effect of 
PNA and, thus, of shifting the noradrenergic ratio of a tissue in favour of PNA. They have 
that effect because of the distributive haemodynamic effect of the turbulencethey induce in 
arteries through the roughness of their surfaces and their protrusion into the arterial lumen 
(v.i).  Because plaques progressively  increase in number and size, they progressivly increase 
microcirculatory flow and the pro inflammatory effects of PNA in arteriosclerosis, of which, 
crucially, a degenerative neurotoxic effect is one.. Consistent with arteriosclerosis being 
associated with a neurotoxic effect, when rabbits were made arteriosclerotic by diet the 
nerves of their pulmonary and aortic arteries eventually ceased to respond to electrical 
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stimulation, or to release [3H] labelled NA 51]. Also consistent is the fact that cardiac 
neurotransmitter stores in dilator cardiac failure are sometimes only 10% of normal [52]. 
The sensitivity of the hypothalamic sympathetic centres. 
The hypothalamic sympathetic centres are highly sensitive to changes in the level of 
afferent sympathetic activity they detect coming from tissues affected by changes in PNA 
stimulation and equally precise in their responses to any change they detect. Those 
conclusions are drawn from the fact that every heart beat is associated with a spike of 
efferent sympathetic activity in the nerves of the skin and muscle [53] and the of the kidney 
[54]. Those spikes, that are unrelated to baroreceptor reflexes [53], are believed to be 
responses by the hypothalamic centres to the momentary increase in afferent sympathetic 
activity they detect coming from the tissues following the momentary increase in the flow 
dependent effect of PNA all tissues experience with every heart beat. 
An appreciation of the high priority the NAS gives to maintaining its set point ratio can be 
gained from the fact that during exercise, when one might anticipate efferent sympathetic 
activity to the microcirculations of muscles would be reduced, in order to increase blood 
flow, is, in fact, increased [55].  
The obligatory role of lateral inhibition (contrast) in the noradrenergic system. 
The  NAS is designed to transmit regulatory information to the adrenergically innervated 
tissues of the body and to do that it displays the three features every system transmitting 
information displays viz., (1) a pattern that encrypts the information to be transmitted and 
(2) a feature that provides contrast, of (3) an appropriate level, to the pattern [56],[57].  The 
failure of any of those features to function appropriately distorts the information a pattern 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
27 
 
is intended to transmit to its target sensor. Bar codes illustrate that principle well.  The 
pattern of lines in a bar code encodes the information it is designed to transmit and the 
colour of the surface on which the pattern is printed provides the contrast needed to detect 
and decode the information the barcode encrypts. If the level of contrast between lines and 
the surface on which it is printed is too great or too little it becomes progressively more 
difficult detect and decode the bar code pattern.  Lateral inhibition is the technical term 
used to connote  the contrast that sharpens the details of signals encrypted in biological 
patterns and it is a feature that has been detected in every biological system receiving or 
transferring information in the body investigated to date [56,] [58]. The importance of 
lateral inhibition is demonstrated by it being recognised as the most potent physiological 
modulator of the excitor component of a system transmitting information [57].  The two 
contrasting patterns of NA involved in transmission of regulatory information are generated 
by NA diffusing from two different sources [58], the adrenergic synapses/boutons in the 
case of NNA and the porous postcapillaries of microcirculations in the case of PNA. Diffusion 
patterns are defined by the ratios between their component fluxes, with the polarity of the 
major flux determining the polarity [59] and, by extension, the effect of a pattern. The 
polarities of the NNA and PNA are speculated to be in planes at right angles to one another 
[13],[42].  Once generated, NA patterns are transformed and propagated throughout a 
tissue by second messengers passing through gap junctions that amplify them and 
accelerate their rate of propagation. The classic example of that type of transformation and 
propagation is the spread of the excitor pattern of NNA stimulation throughout the 
myocardium by the gap junction rich Bundle of His.  
Equivalence between non-neuronal NA in the periphery and the brain? 
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The peripheral NAS is believed to have a close functional counterpart operating within the 
brain [61].  There, what has been termed non-synaptic NA [62] is believed to overspill from 
the brain into its cavities before circulating in the CSF over the brain surface where, I 
speculate, it diffuses back into the brain through the fine pores detected at the bases of the 
cerebral gyri and where the diffusion pattern generated by this diffusion process then 
provides the contrast  brain cells need to detect and respond to the regulatory information 
encrypted in the diffusion pattern of synaptic NA.  The existence of this possible functional  
equivalence between the effects of microcirculatory PNA and non-synaptic NA has the 
potential for regulatory confusion were the two forms of NA to mix,  and to prevent that 
happening may be the reason for the existence of the blood/brain and the blood/CSF 
barriers to NA. Such functional equivalence would also be consistent with the fact that an 
inflammatory brain condition, ůŝŬĞWĂƌŬŝŶƐŽŶ͛Ɛ, is associated with increased CSF flow [63] 
and neuro-degeneration [64]. 
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PART 3. 
This is devoted to analysing the aetiologies of various clinical diseases in the light of the 
fresh concepts described above. Because the analysis is so dependent on microcirculatory 
flow I believe a basic knowledge of the morphology of microcirculations is essential for its 
understanding.  
The morphology of microcirculations.   
Microcirculations are networks of blood vessels ranging in size from arterioles to pulmonary 
arteries. They are constricted by the NNA released from their dedicated adrenergic 
networks [32] and are dilated by the PNA perfusing their lumens.  Their role is to distribute 
blood channelled to the tissues by the arteries, veins and right heart and drained from the 
tissues by two interconnected systems, whose existence is visibly exemplified by the venae 
comites in skeletal muscle and the twin pulmonary veins in the lungs. Except for the 
pulmonary circulation, drainage is preferentially into the caval system but if that is not 
possible it takes place into an unvalved network that interconnects with every other 
microcirculation [17] and drains into the vena cava through the azygos  system of veins [65] 
[66]. Because microcirculations have a single supply and a dual drainage system, they 
display the iconic feature of vascular triads, commonly featuring as an arterial vessel flanked 
by twin venous vessels. All microcirculations appear to be modular in construction, with 
each module of possessing an A/V shunt that makes it possible, by diverting its arterial 
inflow, for a microcirculation to be perfused by reflux through either of its twin drainage 
systems. The density of arterial microcirculations increases to the extent their hosts are 
affected by arteriosclerosis [67],[68],[69]. 
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The primary role of microcirculations. 
Since their discovery in the 18th century, the primary role of microcirculations has been and 
still is believed to be nutritional and metabolic.  However doubts about that have existed 
since 1876, at least, when Köester observed that many small veins had more vasa than their 
nutritional needs seemed to justify [70΁͘<ƂĞƐƚĞƌ͛ƐĚŽƵďƚƐŚĂǀĞďĞĞŶƐŚŽǁŶƚŽďĞfully 
justified. Three morphometric studies of the microcirculations of various arteries and veins, 
in the periphery and the brain [71],[72],[73], have found  no correlation  between the 
density of a  microcirculation and the apparent nutritional needs of its host. That and the 
evidence that the capsules of the kidney (v.i.) and liver [46], contain microcirculations that 
have no significant nutritional or metabolic role vis-à-vis their hosts, and the alleged 
presence of typical microcirculations on 3-5 cell thin aortas of young mice, all support  the 
belief that the primary purpose of a microcirculation is to provide its host with the level of 
PNA stimulation it requires to maintain its set point noradrenergic ratio.  In the 
circumstance, the nutritional and metabolic roles some microcirculations serve are seen as 
being secondary and opportunistic.  
Factors affecting microcirculatory flow. 
In terms of its significance turbulence may be considered the most important factor altering 
flow in a microcirculation. If no turbulence existed the absolute axial velocity vector of 
laminar flow would make it impossible for blood to leave an artery and perfuse a 
microcirculation. By its effect of introducing radial components into the velocity  vector of 
blood turbulence pumps  volume, content and momentum [74] from an artery into its 
primary branches and from them into its second order branches supplying its 
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microcirculatory modules  and its third order branches supplying the microcirculatory 
modules of its companion veins [13]. 
Turbulence is induced in every artery at the free margins of its primary branch points by the 
boundary layer of the bloodstream reducing contact with the arterial endothelium and 
releasing some of the shear stress energy it has accumulated. When released, the energy is 
conserved and converted into turbulence [75] that migrates into the primary branches of 
the artery and reaches its peak distributive effect about 2-3 branch diameters downstream 
[76] [77]. There, the openings of the second order branches dedicated to supplying the 
arterial and venous microcirculatory modules are located [78] [79]. The intensity of the 
turbulence at those second order branch points determines the volume of blood that, under 
prevailing conditions, perfuses arterial and venous microcirculatory modules.  
A number of factors stabilise the microcirculatory flow volume and, by extension, the 
noradrenergic set point ratio of a tissue. A stable cardiac output, a stable subdivision of the 
output and baroreceptor reflexes are major upstream factors; a stable level of shear stress 
between the endothelium and the boundary layer of the bloodstream is a major 
downstream factor.  Such stability results in stable intensities of turbulence at branch 
points, and in stable volumes of blood leaving arteries and perfusing microcirculatory 
modules and generating stable levels of PNA stimulation. The level of shear stress between 
the blood stream and the endothelium is micro managed by the ability of the endothelial 
cells to detect the level of longitudinal stress between them and the blood stream [80] and 
to respond to any deviation from the designed level it detects by releasing a factor, like NO, 
that dilates the artery, thereby lowering the stress level, or, that like endothelin, constricts 
the artery and increases the stress level. Extrinsic factors like cholesterol plaques, accessory 
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cervical ribs, stenoses or aneurysms induce pathological turbulence. Depending on the 
intensity of that turbulence those features can shift the noradrenergic ratio of an artery in 
favour of the inflammatory effects of PNA, of which one is believed to be a reduced 
bioavailability of endothelial NO [81].  Consistent with that belief, the beta1 blocker 
nebivolol, by inhibiting ƚŚĞɴ1 agonist effect of microcirculatory PNA, increases NO 
bioavailability [82]. Because reducing NO bioavailability increases the level of shear stress 
between the endothelium and the blood stream it increases the intensity of the turbulence 
induced at branch points and, consequently, it increases the volume of microcirculatory 
flow. That implies the increased inhibitory effect of PNA stimulation on the endothelium 
initiates a positive feedback that progressively reduces NO bioavailability, that has the effect 
of progressively increasing microcirculatory flow and the pro inflammatory effect of PNA.  
Plaques and microcirculatory bloodflow.   
Using monkeys made arteriosclerotic by high fat diets, Heistad and his colleagues have 
demonstrated that cholesterol plaques are associated with increased microcirculatory flow, 
ŝŶĚĞƉĞŶĚĞŶƚŽĨĂŶǇĐŚĂŶŐĞŝŶďůŽŽĚƉƌĞƐƐƵƌĞ͕ŝŶƚŚĞŵŽŶŬĞǇƐ͛ĂŽƌƚŝĐĂŶĚĐŽƌŽŶĂƌǇ
microcirculations. Presumably the turbulence induced by the plaques is responsible for the 
increase.  In one experiment plaques were associated with an increase in flow in the 
microcirculations of thoracic aortas of from 1.3 to 17ml/min/100gm and in the 
microcirculations of abdominal aortas of from 2.2 to 31ml/min/100gm [83]; in another, 
plaques were associated with an increase in flow in the microcirculations of coronary 
arteries of from 3 to 16ml/100gm in one case [84] and 5 to 47 ml/100gm in another [85]. 
Interestingly, in the ůĂƚƚĞƌĞǆƉĞƌŝŵĞŶƚ͕ǁŚĞŶƚŚĞŵŽŶŬĞǇƐ͛ĚŝĞƚƐǁĞƌĞƌĞƚƵƌŶĞĚƚŽŶŽƌŵĂl 
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the plaques receded and the changes in microcirculatory flow reversed spontaneously, 
again independently of  any change in blood pressure.  
The cardiac microcirculation. 
With one exception, the same principles govern the operation of the cardiac 
microcirculation as govern those of arteries in general. So, the cardiac microcirculation 
displays a modular construction, each one servicing a single cardiac chamber, and vascular 
triads that characterise every microcirculation [80]. Similarly, the volume of blood perfusing 
the cardiac microcirculation is determined, under prevailing conditions, by the intensity of 
the turbulence  induced at the root of the aorta [86] when blood is ejected from the left 
ventricle and reduces contact with the edges of the aortic valve, and, by migration, creates 
turbulence close to the origins of the coronary arteries [87], the topological equivalents of 
the second order branches of the heart.   
The major difference between the cardiac and arterial microcirculations is that flow and the 
effect of PNA stimulation is intermittent in the heart, occurring only during diastole. The 
converse is true of NNA stimulation which occurs only in systole. The effect of that 
dichotomy is that NNA and PNA stimulate the heart in isolation and consequently, NNA 
contracts and PNA relaxes the heart to the maximum of both their potentials ʹ an ideal 
situation in an organ designed to act as a two stroke pump.  By analogy with what happens 
in vein grafts harvested in the traditionally manner (v.s.), the effect of unopposed cardiac 
NNA stimulation would be the creation of the maximum possible number of latchbridges 
within the myocardial syncytium, thereby making the heart more rigid during systole , as has 
been observed [80].  Another effect that would be expected to occur during systole, and is 
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believed to occur [86], is a decrease in the diameters of the arterioles and the venules of the 
cardiac microcirculation caused by the loss of the intraluminal dilator effect of PNA. 
At the end of systole, flow returns to normal rapidly in the cardiac microcirculation. That 
causes an equally rapid increase in the flow dependent effect of PNA stimulation on the 
heart, exaggerated by being unopposed by the effect of NNA stimulation. That has the 
effect of cardiac PNA stimulation releasing the maximum possible number of the 
latchbridges created during systole by NNA stimulation and of relaxing the heart to the 
greatest possible extent possible, under the circumstances, during diastole, thus preparing it 
to the greatest extent possible, under prevailing circumstances, for the following episode of 
systole. The evidence that the heart needs to be stimulated by PNA if it is to relax can be 
seen by the fact that when flow is blocked anywhere in the cardiac microcirculation the local 
myocardium goes into sustained spasm due to the latchbridges created by NNA stimulation 
during the prior episode of systole being maintained.  Another effect PNA stimulation would 
be expected to have during diastole, and that it appears to have [80], is an increase in the 
diameters of the venules and arterioles of the cardiac microcirculation caused by the 
intraluminal dilator effect of PNA, in the absence of the constrictor effect of NNA.   
Arteriosclerotic dilator cardiac failure. 
Arteriosclerotic dilator cardiac failure is an inflammatory condition characterised by an 
increased level of efferent sympathetic activity, that is reflected in an increased level of NA 
overspill in the blood draining from the heart.  Normally that level is ~10 ng/min, but in 
dilator failure it can go as high as 131 ng [89]. That increased efferent activity, in turn, is 
believed to be evoked by the effect of the increased afferent activity associated with heart 
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failure [90] that is caused by the increased cardiac microcirculatory flow, caused by the 
pathological turbulence induced at the root of the aorta and in the coronary sinuses by the 
cholesterol plaques and calcifications located on the free edges and the surfaces of the 
aortic valves. The evidence of that increased flow is masked by the increased cardiac 
efferent activity and by two features that reduce the fraction of the flow that reaches the 
postcapillary ŶĞƚǁŽƌŬƐŽĨƚŚĞŚĞĂƌƚ͛ƐŵŝĐƌŽĐŝƌĐƵůĂƚŝŽŶǁŚĞƌĞPNA causes its stimulatory 
effect. The features in question are shunts from the coronaries to the microcirculation of 
the pulmonary artery [91] and the development of a pathological microcirculation on the 
coronary epicardials. The flow of blood into that pathological microcirculation reduces the 
effect of the increased coronary flow in two ways, one, by the simple fact of blood diversion  
from the coronaries into the pathological microcirculation and, two, by the fact that when 
the PNA in the diverted blood diffuses from the pathological microcirculation it constricts 
the coronaries, thus impeding  coronary flow. If the constrictor effect is sufficiently severe, 
as it may be when coronary flow increases during effort, it causes angina pectoris that, 
pharmacologically, but not physiologically [20], is paradoxically responsive to ƚŚĞɴ1 agonist 
effect of beta blockers.  This ͞ƉĂƌĂĚŽǆŝĐĂů͟ constrictor effect is readily duplicated 
experimentally, using ACh and serotonin [92] [93] instead of NA. One explanation for this 
͞ƉĂƌĂĚŽǆŝĐĂů͟ĞĨĨĞĐƚcould be that when PNA diffuses from the pathological microcirculation 
and stimulates the epicardials it converts from being an intraluminal  dilator of the 
pathological microcirculation to being a constrictor of the epicardials.  In doing that the PNA 
would be merely copying the conversion effect ISO and NA display in the CLSV segment 
where ISO dilates and NA constricts the segment when they act on it intraluminally but ISO 
constricts and NA dilates the segment when they stimulate it by diffusion from its 
microcirculation. Consistent with that explanation, beta blockers have what is presently 
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considered to be a paradoxical therapeutic effect on angina [94]. Reinforcing the credibility 
of this explanation is the fact that the lungs have a comparable, though normal, 
arrangement as the heart in terms of having one microcirculation hosting another and of 
being associated with angina of effort in cases of pulmonary hypertension.  
Pulmonary hypertension. 
 
The two microcirculations in the lungs consist of the pulmonary artery and its branches and 
the microcirculation of those vessels [89][92]. Unlike every other microcirculation, the 
microcirculation of the pulmonary artery drains into its host rather than is supplied by it 
[91]. Consequently, when any lesion, plexiform or other, impedes flow in the pulmonary 
artery and its branches it impedes flow in its microcirculation and that impedance, if 
significant, causes blood in the artery to be shunted into its microcirculation and from there 
into the vena cava through the coronary veins, thereby creating a satellite circulation in the 
process that imposes an added burden on the right heart.  And just as when flow increases 
beyond a critical level in the pathological microcirculation of the coronary epicardials and 
causes angina pectoris, when impedance in the pulmonary artery causes a critical increase 
level of reflux in its microcirculation, that can be expected to cause pulmonary angina, due 
in this instance to PNA in the pulmonary  microcirculation causing constriction of the 
pulmonary artery.  Consistent with that stimulating effect of PNA, the endothelial cells of 
the pulmonary artery display a reduced NO bioavailability [95].   
 
The neurotoxic effect of increased PNA stimulation. 
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Given the evidence of the degenerative effect increased PNA stimulation has on the 
adrenergic nerves of varicosities [32] and the evidence that the adrenergic nerves of the 
pulmonary and aortic arteries of rabbits with diet induced arteriosclerosis soon fail to 
respond to electrical stimulation [51], it is not unexpected that the adrenergic nerves of 
failing arteriosclerotic hearts display evidence of progressive damage in that condition [52].  
Because of that the cardiac nerves in dilator failure eventually reach the stage where they 
can no longer respond  fully to the increased level of efferent sympathetic activity they 
receive from the hypothalamus . That predictably results in the NAS being no longer capable 
of maintainŝŶŐƚŚĞŚĞĂƌƚ͛ƐƐĞƚƉŽŝŶƚnoradrenergic ratio, which progressively shifts in favour 
of the degenerative effect of increased PNA stimulation.  Evidence of the damage caused by 
by that increased PNA stimulation includes depletion of their neurotransmitter stores to as 
little as 10% of normal, sometimes, and a drastic reduction in the quantity of 
neurotransmitter released per nerve impulse [96].  Other critical consequences of the shift 
in favour of cardiac PNA stimulation include an increased distensibility of the heart [97], 
resulting from a shift in favour of latchbridge release as against latchbridge formation in the 
myocardial syncytium, a lengthening of the cardiomyocyte sarcomeres to a suboptimal 2.4-
2.5 µm [96] and a remodeling of the heart from an asymmetrical prolate ellipse shape to a 
more pliable, less efficient spherical shape [98]. 
 
Hypertrophic Cardiomyopathy. 
 
Hypertrophic cardiomyopathy is a non-inflammatory genetic condition, affecting all ages,  
associated with mutations encoding the sarcomeric proteins.  In terms of blood supply and 
PNA stimulation, hypertrophied hearts are characterised by features that either cause or 
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reflect a tendency towards cardiac ischaemia.  Those features  include coronary arteries 
with thickened walls and narrowed lumens [99], evidence of decreased coronary flow [100], 
[101], evidence of impaired myocardial blood flow during stress [102] and of an inadequate  
increase in myocardial blood flow in response to dypyridamole infusion [103].  All those 
features either actually or tend to reduce cardiac microcirculatory flow volume and shift the 
cardiac noradrenergic ratio in favour of the growth promoting effect of NNA stimulation, 
thus causing the heart to hypertrophy. That same hypertrophy effect occurs in preeclampsia 
when the uterus experiences a reduction in blood flow and becomes hypertrophied [49]. 
Consistent with cardiac hypertrophy not being an inflammatory condition, beta blockers do 
not modify the course of the condition [104] and the condition is characterised by a 
reduction in efferent cardiac sympathetic activity [105].  
Renal Hypertension. 
A kidney possesses three networks of fine blood vessels, of which two are well known, the 
glomerular and the peritubular. The third, little known, is located in the capsule of the 
kidney (Fig 6). The first two networks are not microcirculations in the technical sense. Their 
role is purely executive, maintaining the salt and water balance of the body under regulation 
by the renal nerves and intrinsic autoregulatory mechanisms. The fine network of vessels in 
the renal capsule is a true microcirculation, as evidenced by the presence of vascular triads 
(fig 6) and A/V shunts that appear to open into the subcapsular stellate veins. 
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FIG 6 
Photograph of the renal microcirculation located in the capsule of a kidney with (inset) a 
micrograph of a section of a vascular triad. 
 The renal capsular microcirculation (RCM) receives supply from the renal and lobar arteries 
but it is functionally independent of those sources, as evidenced by the fact that it  
continues to be perfused when the renal artery is thrombosed or the kidney is avulsed 
[106].  As its size and peripheral location would indicate the RCM has no metabolic or 
nutritional role in relation to the renal parenchyma, they being adequately provided for by 
the periglomerular and  peritubular networks.  The role of the RCM seems to be purely 
regulatory, providing the kidney with the PNA stimulation it needs to maintain its set point 
noradrenergic ratio. 
Possibly reflecting the multi lobular development of the kidney, the RCM is exceptional in 
being supplied by several known named arteries, including the aorta [61], renal, lobar, 
subdiaphragmatic and adrenal [107] [108].  Given that the basic cardiac output is constant, 
except in pregnancy, whenever blood flow is impeded anywhere in the body or a 
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capacitance is reduced, blood is necessarily displaced to other parts of the circulation. And 
because the RCM has so many inflows, it can be expected to receive a disproportionate 
fraction of any displaced blood. That, in turn, implies when any factor blocks blood flow 
anywhere in the body that it would lead to a disproportionate increase in renal afferent 
sympathetic activity and evoke a disproportionate increase in renal efferent sympathetic 
activity, that would cause a disproportionate increase in JGA stimulation and hypertension, 
presumably designed to restore the normal blood flow pattern.  
Consistent with this analysis, a reduction in splanchnic capacitance [109],  a reduction in 
cerebral blood flow caused by fibroplasia of the carotids and vertebral arteries [110], 
vascular fibroplasias in general [111], compression of the aorta distal to the renal artery in 
preeclampsia, causing  a minimum 40-50% reduction in blood flow distal to the compression 
[112΁͕ƚŚĞŽďƐƚƌƵĐƚŝŽŶŽĨŵƵůƚŝƉůĞŵŝĐƌŽĐŝƌĐƵůĂƚŽƌǇŵŽĚƵůĞƐŝŶdĂŬĂǇĂƐƵ͛ƐĂƌƚĞƌŝƚŝƐ΀ϯ9], 
Williams Syndrome [40] and polyarteritis nodosa [111], the roughening of the aorta by 
cholesterol  plaques, causing pathological turbulence that  increases inflow to the many 
different vessels originating in the aorta and supplying the RCM, are all conditions that 
cause blood to be preferentially displaced into the renal microcirculation and are known to  
be associated  with hypertension. In addition to this list, the increased microcirculatory flow 
associated with polycythemia [113] is associated with hypertension [114]. 
 Because each renal artery receives about 10% of the total cardiac output, any significant 
impedance to flow in that vessel is particularly likely, because its origin is so close to the 
origins of the arteries supplying the renal microcirculation, to result in a significant 
redistribution of blood to that microcirculation and cause hypertension. Consistent with 
that analysis any obstruction that reduces renal blood flow by about 60-70% is commonly 
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associated with hypertension [111]. In the circumstances, it is understandable why 
Goldblatt caused hypertension when he placed a clip on a renal artery.  
That the renal capsule has a factor responsible for causing hypertension has been known for 
more than a century.  That was discovered by chance in the late 19th century when, as a final 
resort, some European physicians empirically decapsulated the kidneys of patients with 
terminal renal disease and preeclamptic hypertension and found it had a therapeutic effect 
in both conditions [115] [116] [117]. However, because of the morbidity and mortality 
associated with the procedure it was abandoned around the middle of the last century. 
Nowadays decapsulation is purely an experimental procedure that when employed is 
associated with significant changes in kidney function [118].  
Consistent with increased renal PNA stimulation being the cause of hypertension  that 
condition is a recognised inflammatory disorder [119].  And consistent with that beta 
blockers and renal afferent nerve ablation have a significant therapeutic effect on the 
condition [120].  
Preeclampsia. 
Preeclampsia is unique in being associated with two contrasting shifts in the noradrenergic 
ratio.  /ŶƚŚĞĐĂƐĞŽĨƚŚĞŵŽƚŚĞƌ͛ƐƚŝƐƐƵĞƐŝŶŐĞŶĞƌĂůthe shift is in favour of PNA; in her 
uterus and conceptus it is believed to be in favour of NNA [48]. Consistent with that 
dichotomy, one investigator has claimed preeclampsia has a heterogenous cause [123]. The 
contrasting shifts in ratios in preeclampsia are believed to result from the pregnant uterus 
becoming retroflexed and compressing the aorta against the lordotic curve of the spine 
[122]  or the brim of the pelvis [48]  with the result, in both cases, of reducing blood flow 
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beyond the compression by a minimum 40-50 % [123] and causing  ischaemia of the uterus 
and the conceptus which are supplied by arteries originating distal to the compression.  
Given the stability of the cardiac output referred to earlier and the 30% gestational increase 
in blood volume associated with pregnancy, that exceptionally  large percentage reduction 
in blood flow beyond the aortic compression  is necessarily associated with an exceptionally 
large diversion of blood flow to the microcirculations of the arteries originating upstream of 
the compression. Given the RCM receives a disproportionally large fraction of any diverted 
flow, hypertension is one predictable feature of preeclampsia. Other predictable and 
observed features of preeclampsia include an increase in renal efferent sympathetic activity 
[121] and a tendency to develop left ventricular failure due to increased flow in the cardiac 
microcirculation [124]..  
Because of the ischaemia they experience in preeclampsia, the uterus and the conceptus 
experience a decreased level of PNA stimulation and, by default, a relatively increased level 
of NNA stimulation.  And just as the heart hypertrophies when it experiences an equivalent 
shift in hypertrophic cardiopathy, the uterus hypertrophies in preeclampsia [49].  LIkewise, 
just as the vessels of a microcirculation constrict when they experience a decrease in the 
dilator effect of intraluminal PNA stimulation, the spiral uterine arteries, which represent 
the microcirculation of the uterus, also display a reduction in diameter, with consequent 
poor placental development, in preeclampsia.  Moreover, because the child in the uterus 
experiences a reduction in PNA stimulation in preeclampsia, the use of beta blockers for the 
treatment of the maternal hypertension in preeclampsia is contraindicated, because their 
use reduces still further the level of PNA stimulation the child needs to maintain its proper 
PNA/NNA ratio and causes it respiratory depression [125] [126]. Finally, the fact 
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preeclampsia involves two contrasting pathologies, any drug therapy designed to benefit 
one is likely to aggravate the other. That is the reason, I believe, why modern therapeutic 
advances have done so little to improve the outcome for patients with preeclampsia 
compared to what they have done to improve the outcome for patients suffering from other 
serious conditions like cardiac failure and hypertension.  
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DISCUSSION 
 
Because the findings on which the hypothesis and the paradigm of the NAS presented in this 
paper are based have not been independently verified, nor can they be experimentally 
duplicated in vivo in a healthy subject, they cannot be validated in the normal way.  
However, on the grounds of what they have led to the findings deserve a certain credibility. 
These grounds include the creation of a paradigm of the NAS that can account for several 
features associated with the operation of the sympathetic system that up to now have not 
been satisfactorily explained and the generation of a hypothesis that provides a unified, 
internally consistent explanation for a variety of inflammatory and non inflammatory 
disorders, affecting different tissues, and  that rationalises the evolutionary conservation of 
PNA, the existence of valve aggers and the blood/brain and blood/ CSF barriers to NA. 
Further adding to the credibility of the findings is the fact they can resolve a number of 
pharmacological anomalies, such as the paradoxical use of beta blockers to treat angina and 
hypertension and provide an explanation for the long questioned [127] intriguing claim by 
Furchgott and Zawadski [128] that endothelial cells are obligatory for low concentrations of 
ACh to relax vascular smooth muscle cells. That claim resulted from an experiment, 
independently famous for having led to the discovery of NO, where Furchgott and his 
colleague abraded the endothelium of an aortic strip and discovered the strip no longer 
relaxed in response to stimulation by low concentrations of ACh because, they contended, 
endothelial cells had a factor that relaxed vascular smooth muscle but that required 
stimulation by ACh to be activated.  The validity of that claim has been disputed for years 
[127] on the grounds that it is difficult to conceive why endothelial cells would have 
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muscarinic receptors to enable intraluminal ACh activate a factor obligatory for the 
relaxation of vascular smooth muscle when plasma and red blood cells contain a range of 
specific and non specific esterases to ensure they would never experience stimulation by 
ACh͘ƌĞǀŝĞǁŽĨ&ƵƌĐŚŐŽƚƚ͛ƐƉĂƉĞƌƌĞǀĞĂůƐŚĞ had failed to appreciate the greater sensitivity 
of vascular smooth muscle to drugs stimulating it by diffusion from a vascular 
microcirculation than intraluminally. So, when Furchgott reduced the concentration of ACh 
below the threshold at which it contracted the  aortic strip acting intraluminally, the drug 
still retained the ability to relax it by stimulating it by diffusion from its microcirculation. 
Believing an endothelial factor had to have been responsible for this relaxation effect, 
Furchgott abraded the endothelium and found the low concentration drug no longer 
relaxed the strip, thus apparently confirming the validity of his hypothesis.  However, as 
ĞǀŝĚĞŶƚĨƌŽŵĂƉŚŽƚŽŐƌĂƉŚŝŶ&ƵƌĐŚŐŽƚƚ͛ƐƉĂƉĞƌ͕ŝƚŝƐŵŽƌĞůŝŬĞůǇŚĨĂŝůĞĚƚŽƌĞůĂǆƚŚĞƐƚƌŝƉ
because the abraded endothelial cells had plugged the primary branch openings of the strip 
and, thus, prevented ACh from stimulating the strip through its microcirculation and 
relaxing it, in the same way as an injection of 50µM Ach relaxed the canine tibial vein when 
it stimulated it by diffusion from its microcirculation, after having been injected into the 
lumen of the cranial tibial artery [13].  
Adding credibility to the hypothesis presented that, in essence, claims health depends on a 
balance between flow dependent effect of PNA and NNA is the fact that that claim 
resonates, to a greater or lesser extent, with several other long recognised claims. One, 
credited to Recklinghausen [129], goes back to 1883, and claims that changes in 
microcirculatory flow cause remodeling changes in arteries.  Another claim goes back much 
further, to beyond the time of Galen, and claims that bleeding patients has a therapeutic 
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effect. That it indeed may have would seem to be borne out by the fact that the procedure 
ƌĞŵĂŝŶĞĚƉŽƉƵůĂƌƌŝŐŚƚƵƉƚŽƚŚĞƚŝŵĞŽĨtŝůůŝĂŵKƐůĞƌ͕͞dŚĞ&ĂƚŚĞƌŽĨDŽĚĞƌŶDĞĚŝĐŝŶĞ͕͟
who died in 1919 and who allegedly used it on occasions.  The present hypothesis would 
rationalise any therapeutic success of bleeding by claiming that bleeding necessarily reduces 
microcirculatory flow and, with it, the flow dependent, malign effect of PNA stimulation. 
Two further beliefs, with a more tenous resonance to the present hypothesis, include 
,ŝƉƉŽĐƌĂƚĞƐ͛ĐƌĞĚŽƚŚĂƚ͚ůŝŬĞĐƵƌĞƐůŝŬĞ͛ĂŶĚƚŚĞŽƌŝĞŶƚĂůŶŽƚŝŽŶƚŚĂƚŚĞĂůƚŚĚĞƉĞŶĚƐŽŶ the 
maintenance of a balance between the negative effects of Yin and the positive effects of 
Yang.  
If increased PNA stimulation has the degenerative and ageing effects credited to it in this 
article then the concept of introducing low dose beta blockade at an age when people are 
still apparently healthy should be considered. Or, alternatively, it might be worth 
determining the value oĨĂŶŝŶĚŝǀŝĚƵĂů͛Ɛnoradrenergic ratio at around thirty, when he/she is 
healthiest, and then attempting to maintain that value long term by the use of an 
appropriate combination of alpha and beta blocker drugs. Or, assuming the rationalisation 
offered for the therapeutic benefit of bleeding is valid, then it might be worth exploring the 
possibility of developing a less dangerous method than bleeding for reducing the overall 
levels of PNA stimulation in patients with inflammatory conditions. That could involve the 
development of an extracorporeal means of dialysing ĂƉĂƚŝĞŶƚ͛ƐPNA or the use of exchange 
ƚƌĂŶƐĨƵƐŝŽŶŽĨĂƉĂƚŝĞŶƚ͛ƐŽǁŶƐƚŽƌĞĚďůŽŽĚ͕ƉƌĞǀŝŽƵƐůǇĚŝĂůǇƐĞĚĨƌĞĞŽĨWE͘ The belief that 
those procedures would have a worthwhile therapeutic effect is consistent with the 
rejuvenating effect of heterochronic parabiosis.  That is a classical experimental procedure 
where the circulations of an elderly and a young animal are joined and within a few months 
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the tissues and cognitive abilities of the elderly animal appear to be rejuvenated [130]. 
Based on the hypothesis presented here that rejuvenation effect would be explained as 
having been caused by the noradrenergic system of the vigorous young animal decreasing 
the concentration of PNA in the common circulatory pool to the level appropriate to young 
animals, which is significantly lower than that in elderly animals.  That would be expected to 
have the effect of shifting the balance between the stimulatory effects of PNA and NNA in 
the elderly animal in favour of the anti-inflammatory, growth promoting effects of NNA. 
Finally, this paper has highlighted what is believed to be the crucial role of cholesterol 
plaques in increasing the damaging flow dependent effects of PNA. That should encourage 
those working in the relevant fields of molecular biology to redouble efforts to develop a 
vaccine or other means of delaying the appearance or reducing the size and number of 
plaques. It should also influence those trying to persuade the public of the importance of 
diet in reducing plaque formation and heart disease to target their message at a younger 
age group then they do at present. 
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